Skip to main content

Table 5 Incidence of adverse events as a function of parasitaemia

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

 

Positive parasitaemia

Negative parasitaemia

Undetermined parasitaemia

p

N = 11,141

N = 3435

N = 585

Any AE

12.9% [12.3%; 13.5%]

13.7% [12.5%; 14.8%]

11.8% [9.2%; 14.4%]

0.333

Any SAE

0.7% [0.5%; 0.8%]

0.6% [0.4%; 0.9%]

0.5% [0.0%; 1.1%]

0.905

Any potentially ASAQ-related AE

5.6% [5.2%; 6.1%]

5.4% [4.6%; 6.1%]

4.4% [2.8%; 6.1%]

0.423

  1. The occurrence of adverse events is presented as the incidence rate (%) with its 95% confidence interval
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us